ID
45656
Beschreibung
Principal Investigator: Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA MeSH: Melanoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001241 This study contains sequence data from 15 patients with stage IV melanoma, including the whole genome sequence of 15 metastatic tumors and corresponding normal blood samples from 13 cases, and targeted capture sequence of four synchronous metastatic samples from two additional cases. These data provide a comprehensive survey of the clonal architecture and associated driver mutations in metastatic melanoma.
Link
Stichworte
Versionen (1)
- 21.03.23 21.03.23 - Simon Heim
Rechteinhaber
Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA
Hochgeladen am
21. März 2023
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs001241 Clonal Architectures and Driver Mutations in Metastatic Melanomas
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
C0680251 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1321872 (UMLS CUI [1,4])